학술논문
LBA12 Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S1305-S1306
Subject
Language
ISSN
0923-7534